Clinical Trials in Birmingham, UK

Clinical Trials in Birmingham

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Clear sponsor filter

Site city

All 13 cities

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Active, closed

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

NCT04404283Diffuse Large B-cell Lymphoma

Seagen, a wholly owned subsidiary of Pfizer

Phase 3

239

Birmingham, London, Sandwich

2020-08-20

Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma

Seagen, a wholly owned subsidiary of Pfizer

Phase 1

1,006

Sutton, Birmingham, London

2020-06-08

Active, closed

A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

NCT03975647HER2-positive Breast Cancer

Seagen, a wholly owned subsidiary of Pfizer

Phase 3

466

Truro, Edinburgh, Birmingham, London, Manchester, Sutton

2019-10-02

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 September 2026. https://priyalifescience.com/clinical-trials-uk/city/birmingham

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →